Key Takeaways
- Halo ($145,000–$210,000 as a Joule module) uses Hybrid Fractional Laser (1470nm non-ablative + 2940nm ablative in a single pass); REVIVO™ Dual Summit ($29,000 sale price; $42,000 regular price) uses a Dual-Wavelength Non-Ablative Fractional Fiber Laser (1550nm Erbium Fiber + 1927nm Thulium Fiber).
- Used pricing: Halo approximately $80,000–$140,000 vs. REVIVO™ Dual Summit no established public secondary market.
- Per-session economics: Halo $1,200–$2,500 vs. REVIVO™ Dual Summit varies by market, treatment area, and practice pricing.
- Treatment protocol: Halo 1–3 sessions spaced 4–6 weeks apart vs. REVIVO™ Dual Summit treatment protocols vary depending on indication and physician treatment plan.
Why This Comparison Matters
Halo and REVIVO™ Dual Summit occupy the same advanced skin resurfacing category but take different technological approaches. Halo (Sciton) combines 1470nm non-ablative and 2940nm ablative wavelengths into a single hybrid treatment, while REVIVO™ Dual Summit combines 1550nm Erbium Fiber and 1927nm Thulium Fiber fractional lasers that can be used individually or together depending on the clinical indication. Both are FDA-cleared platforms and are designed to improve skin texture, pigmentation, fine lines, wrinkles, and acne scars.
Physicians often compare these systems when looking for a premium fractional resurfacing platform but with significantly different acquisition costs. Halo has become a benchmark in hybrid fractional resurfacing, while REVIVO™ Dual Summit offers dual-wavelength fractional technology with a broader range of treatment modes, larger scan sizes, continuous-motion treatment capability, optional vaginal rejuvenation, and no swipe-card treatment restrictions. This comparison focuses on pricing, technology, clinical evidence, workflow, and overall practice fit.
Side-by-Side Specifications
| Halo | REVIVO™ Dual Summit | |
| Manufacturer | Sciton | Rejuva Fresh |
| Technology | Hybrid Fractional Laser (1470nm non-ablative + 2940nm ablative) | Dual-Wavelength Fractional Fiber Laser (1550nm Erbium Fiber + 1927nm Thulium Fiber) |
| Price (New) | Approximately $145,000–$210,000 (JOULE module) | Approximately $29,000 |
| Price (Used) | Approximately $80,000–$140,000 | No established public secondary market |
| Treatment Time | 30–45 minutes | Approximately 20–45 minutes |
| Sessions | 1–3 sessions (typically 4–6 weeks apart) | 1–4 sessions depending on indication |
| Per Session | Approximately $1,200–$2,500 | Approximately $700–$2,000 |
| Annual Consumables | Approximately $2,000–$5,000 | No swipe cards or shot restrictions. Routine handpiece cleaning and disinfection are supported by the built-in UV sterilization chamber, helping keep ongoing operating costs low. |
| Annual Maintenance | Approximately $5,000–$10,000 | Not publicly disclosed; includes lifetime technical support and 3-year free parts replacement warranty |
| FDA Status | FDA-cleared (2015) | FDA-cleared (510(k) K240474) |
Technology
|
Halo |
REVIVO™ Dual Summit 1927/1550 Fractional Laser System |
|
Technology: Hybrid Fractional Laser (1470nm non-ablative + 2940nm ablative in a single pass). First and only hybrid fractional laser that delivers ablative and non-ablative wavelengths in a single pass. Dynamic Thermal Optimization adjusts energy in real time to maintain target temperature. |
Technology: Dual-Wavelength Non-Ablative Fractional Fiber Laser (1550nm erbium fiber + 1927nm thulium fiber). Physicians can select 1550nm, 1927nm, or Dual Mode to treat both deeper dermal remodeling and more superficial pigmentation concerns from a single platform. The system also includes a continuous-motion roller handpiece for hair restoration and facial treatments and an optional vaginal treatment handpiece. |
Clinical Evidence
|
Halo |
REVIVO™ Dual Summit 1927/1550 Fractional Laser System |
|
Strong peer-reviewed base. Multiple blinded-evaluator studies demonstrating significant improvements in photodamage, fine lines, skin texture, and overall skin quality. |
Built on established 1550nm erbium fiber and 1927nm thulium fiber fractional laser technology. The underlying dual-wavelength approach is supported by more than 50 peer-reviewed publications, over 35,000 histologies, and more than 25 FDA-cleared indications, although long-term independent clinical literature specific to the REVIVO™ Dual Summit platform is more limited than that of legacy systems. |
Treatment Experience
|
Halo |
REVIVO™ Dual Summit 1927/1550 Fractional Laser System |
|
30–45 minutes per session. Recommended protocol: 1–3 sessions spaced 4–6 weeks apart. Treatment areas: Face, Neck, Décolletage, Hands, Arms. Patients typically tolerate this platform well when operated by trained clinicians |
Treatment time varies by indication, treatment area, and selected parameters. Physicians can select 1550nm, 1927nm, or Dual Mode using either the fractional or continuous-motion roller handpiece. Treatment areas include the face, neck, chest, arms, hands, legs, back, support for hair restoration, and an optional vaginal rejuvenation handpiece. |
Practice Fit
|
Halo |
REVIVO™ Dual Summit 1927/1550 Fractional Laser System |
|
High-end dermatology and plastic surgery practices with an established skin resurfacing patient base. Practices that already own or plan to build the Sciton Joule ecosystem. |
Dermatology, plastic surgery, aesthetic medicine, and medical spa practices seeking a versatile dual-wavelength fractional resurfacing platform. Well suited for practices that want to treat pigmentation, acne scars, wrinkles, sun damage, hair restoration, and other resurfacing indications while benefiting from multiple treatment modes, low ownership costs, lifetime technical support, and no swipe-card treatment restrictions. |
Pros and Cons
Halo Pros
-
Hybrid ablative plus non-ablative design in one pass
-
Dynamic Thermal Optimization helps maintain consistent energy delivery
-
Built on the Sciton Joule platform alongside BBL and MOXI modules
-
Strong premium positioning supports high per-session pricing
Halo Cons
-
Joule platform pricing runs well above category competitors
-
Requires 3–5 days of social downtime (sandpaper texture)
-
Operator training is involved and takes weeks to master
REVIVO™ Dual Summit Pros
-
Selectable 1550nm, 1927nm, or Dual Mode treatment in a single platform
-
Continuous-motion roller handpiece expands treatment versatility for facial treatments and hair restoration
-
No swipe cards or shot restrictions, helping reduce ongoing operating costs
-
Larger scan sizes improve treatment efficiency for larger treatment areas
REVIVO™ Dual Summit Cons
-
Smaller installed base than long-established fractional laser platforms
-
Less independent long-term published clinical literature than legacy systems
Practices evaluating additional resurfacing options can also explore our laser skin resurfacing machines, including CO2, Erbium, and Thulium laser systems.
The Verdict
Choose Halo if your practice prioritizes Sciton's ecosystem, brand recognition, or the clinical advantages of Hybrid Fractional Laser technology. Halo is well suited for high-end dermatology and plastic surgery practices with an established skin resurfacing patient base, particularly those already using—or planning to build around—the Sciton Joule platform. The advantages that matter most include its hybrid ablative and non-ablative treatment delivered in a single pass and Dynamic Thermal Optimization, which helps maintain consistent energy delivery. The primary tradeoff is the significantly higher acquisition cost associated with the Joule platform.
Choose REVIVO™ Dual Summit 1927/1550 Fractional Laser System if your practice values dual-wavelength flexibility, broader treatment versatility, and lower acquisition costs. REVIVO™ Dual Summit combines 1550nm erbium fiber and 1927nm thulium fiber technology in a single platform, allowing physicians to select 1550nm, 1927nm, or Dual Mode treatments. Additional advantages include the continuous-motion roller handpiece, optional vaginal treatment capability, and operation without proprietary swipe cards or shot restrictions. The primary tradeoff is a smaller installed base and less long-term independent clinical literature than legacy fractional laser platforms.
For practices with limited capital, the price difference is significant. Halo typically starts around $145,000–$210,000, while the REVIVO™ Dual Summit is currently offered by Rejuva Fresh for $29,000. While used Halo systems are commonly available on the secondary market, there is currently no established public secondary market for REVIVO™ Dual Summit.
Ultimately, the right choice depends on your patient population, treatment goals, existing technology, workflow preferences, and long-term practice strategy. Consider the total cost of ownership, expected treatment volume, available training, and the clinical outcomes you want to deliver before making a purchasing decision.
Frequently Asked Questions
Which is more expensive, Halo or REVIVO™ Dual Summit?
Halo is typically priced at $145,000–$210,000 (as a Joule module), while the REVIVO™ Dual Summit is listed by Rejuva Fresh at $29,000 (regular price $42,000). Halo generally commands higher per-session pricing, while REVIVO™ offers a substantially lower acquisition cost. Beyond the purchase price, practices should compare to
Which has better clinical evidence, Halo or REVIVO™ Dual Summit?
Halo has a strong peer-reviewed evidence base with multiple blinded-evaluator studies demonstrating improvements in photodamage, skin texture, and fine lines. REVIVO™ Dual Summit is built on 1927nm and 1550nm dual-wavelength fractional laser technology, which is supported by more than 50 peer-reviewed publications, over 35,000 histologies, and more than 25 FDA-cleared indications. When evaluating any platform, physicians should consider study quality, patient populations, and long-term clinical outcomes rather than publication count alone.
Is Halo or REVIVO™ Dual Summit more popular in dermatology practices?
Halo has a well-established presence in dermatology and plastic surgery practices. REVIVO™ Dual Summit is a newer platform that combines dual-wavelength fractional fiber laser technology with additional treatment versatility. Popularity varies by region and practice type, so physicians should consider clinical capabilities, workflow, training, and long-term support rather than brand recognition alone.
Are there safety concerns with Halo or REVIVO™ Dual Summit?
Both devices are intended for professional medical or aesthetic use and should be operated by appropriately trained practitioners. Halo has an established safety profile based on years of clinical use. REVIVO™ Dual Summit incorporates multiple safety features, including precise energy selection, intelligent dosimetry, interchangeable treatment heads, and integrated cooling. As with any energy-based device, practitioners should review current FDA safety information, manufacturer guidance, and adverse event reports before purchasing or using a system.
Can I use Halo and REVIVO™ Dual Summit in the same practice?
Yes. Some practices operate multiple fractional laser platforms to address different patient populations or treatment preferences. The tradeoff is additional training, equipment investment, and workflow complexity. Many practices instead choose one platform that best matches their clinical goals, budget, and patient demand.
What's the resale value comparison between Halo and REVIVO™ Dual Summit?
Used Halo systems commonly appear on the secondary market, with pricing varying by age, condition, software version, and included accessories. REVIVO™ Dual Summit currently has no established public secondary market, making long-term resale value more difficult to estimate. Practices should consider manufacturer support, warranty, and expected service life alongside potential resale value.
Halo vs REVIVO™ Dual Summit: Which is better for dermatology practices in 2026?
The answer depends on your existing equipment, patient mix, treatment goals, and budget. Halo remains a premium hybrid fractional platform with a long clinical history. REVIVO™ Dual Summit offers selectable 1550nm, 1927nm, or Dual Mode treatments, multiple handpieces, and a substantially lower acquisition cost. Comparing total cost of ownership, clinical capabilities, and expected patient demand over several years provides a better purchasing framework than comparing specifications alone.
Halo vs REVIVO™ Dual Summit: 2026 update on features and clinical evidence?
As of 2026, Halo continues to be offered as part of the Sciton Joule platform. REVIVO™ Dual Summit is offered by Rejuva Fresh as a dual-wavelength fractional fiber laser platform featuring 1550nm, 1927nm, and Dual Mode treatment options. Physicians should continue monitoring manufacturer updates, FDA information, and new peer-reviewed clinical publications when evaluating either platform.
How do I choose between Halo and REVIVO™ Dual Summit for my practice?
Start by identifying your practice's priorities, such as treatment versatility, patient demographics, workflow, acquisition budget, and expected return on investment. Score each platform against those priorities rather than comparing feature lists alone. If the results are similar, secondary considerations—including manufacturer support, training, financing options, warranty coverage, and long-term operating costs—often become the deciding factors.
Are there better alternatives to Halo or REVIVO™ Dual Summit in the skin resurfacing category?
Halo and REVIVO™ Dual Summit are two strong options within the fractional skin resurfacing category, but the right choice depends on your practice's treatment goals, patient population, budget, and workflow. Rather than focusing solely on brand recognition or purchase price, compare each platform's technology, clinical capabilities, total cost of ownership, training, warranty, and long-term manufacturer support before making a purchasing decision.
Explore Your Options
Still comparing fractional laser options for your practice? Contact Rejuva Fresh to discuss your treatment goals, equipment requirements, or schedule a virtual demo.